Administrative Receiver
Company Information for GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
RSM RESTRUCTURING ADVISORY LLP, 3 HARDMAN STREET, MANCHESTER, M3 3HF,
|
Company Registration Number
04173789
Private Limited Company
In Administration Administrative Receiver |
Company Name | ||||
---|---|---|---|---|
GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED | ||||
Legal Registered Office | ||||
RSM RESTRUCTURING ADVISORY LLP 3 HARDMAN STREET MANCHESTER M3 3HF Other companies in OX14 | ||||
Previous Names | ||||
|
Company Number | 04173789 | |
---|---|---|
Company ID Number | 04173789 | |
Date formed | 2001-03-06 | |
Country | ||
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | In Administration Administrative Receiver | |
Lastest accounts | 30/06/2016 | |
Account next due | 31/03/2018 | |
Latest return | 14/01/2016 | |
Return next due | 11/02/2017 | |
Type of accounts | FULL | |
VAT Number /Sales tax ID |
Last Datalog update: | 2018-09-07 01:18:21 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
RICHARD EDWARD BUNGAY |
||
JAMES ANTHONY OTTER |
||
FRASER ANDREW SKIRROW |
||
IAN JOSEPH SMITH |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
MEDINNOVATE LTD |
Director | ||
BRYAN GEOFFREY MORTON |
Director | ||
MARK CARNEGIE-BROWN |
Director | ||
MARK RICHARD KIRBY |
Director | ||
CHARLES DAVID OGILVY POTTER |
Director | ||
FRASER ANDREW SKIRROW |
Director | ||
JAMES ANTHONY OTTER |
Director | ||
VANESSA JANE YOUNG |
Company Secretary | ||
SIMON JONES |
Company Secretary | ||
RUSSELL SMITH |
Director | ||
SIMON JONES |
Director | ||
CHARLES STUART WEBB SWINGLAND |
Director | ||
MARGARET ANNE POTTER |
Company Secretary | ||
MARGARET ANNE POTTER |
Director | ||
SWIFT INCORPORATIONS LIMITED |
Nominated Secretary | ||
INSTANT COMPANIES LIMITED |
Nominated Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
ELLIPSON LIMITED | Director | 2003-09-04 | CURRENT | 2003-09-04 | Active | |
MEDINNOVATE LTD | Director | 2004-12-21 | CURRENT | 2004-12-21 | Active |
Date | Document Type | Document Description |
---|---|---|
GAZ2 | Final Gazette dissolved via compulsory strike-off | |
AM23 | Liquidation. Administration move to dissolve company | |
AM15 | Liquidation. Notice of resignation of administrator | |
AM01 | Appointment of an administrator | |
AM10 | Administrator's progress report | |
AM06 | Notice of deemed approval of proposals | |
AM03 | Statement of administrator's proposal | |
AM02 | Liquidation statement of affairs AM02SOA/AM02SOC | |
AD01 | REGISTERED OFFICE CHANGED ON 12/09/17 FROM 45B Western Avenue Milton Park Abingdon Oxfordshire OX14 4RU | |
AM01 | NOTICE OF ADMINISTRATOR'S APPOINTMENT:LIQ. CASE NO.1:IP NO.00013790,00008931 | |
AM01 | NOTICE OF ADMINISTRATOR'S APPOINTMENT:LIQ. CASE NO.1:IP NO.00013790,00008931 | |
AP01 | DIRECTOR APPOINTED MR JAMES ANTHONY OTTER | |
AA | FULL ACCOUNTS MADE UP TO 30/06/16 | |
CS01 | CONFIRMATION STATEMENT MADE ON 08/03/17, WITH UPDATES | |
LATEST SOC | 20/02/17 STATEMENT OF CAPITAL;GBP 1005.5752 | |
SH01 | 19/01/17 STATEMENT OF CAPITAL GBP 1005.5752 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR BRYAN MORTON | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR MEDINNOVATE LTD | |
AP01 | DIRECTOR APPOINTED MR FRASER ANDREW SKIRROW | |
MR01 | REGISTRATION OF A CHARGE / CHARGE CODE 041737890004 | |
CS01 | CONFIRMATION STATEMENT MADE ON 14/01/17, WITH UPDATES | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
RES01 | ADOPT ARTICLES 22/12/2016 | |
RES10 | Resolutions passed:
| |
TM01 | APPOINTMENT TERMINATED, DIRECTOR MARK CARNEGIE-BROWN | |
AA01 | Previous accounting period shortened from 31/12/16 TO 30/06/16 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/15 | |
LATEST SOC | 12/02/16 STATEMENT OF CAPITAL;GBP 980.2802 | |
AR01 | 14/01/16 ANNUAL RETURN FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 31/12/14 | |
LATEST SOC | 18/03/15 STATEMENT OF CAPITAL;GBP 980.2802 | |
AR01 | 14/01/15 FULL LIST | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/13 | |
AP01 | DIRECTOR APPOINTED MR RICHARD EDWARD BUNGAY | |
LATEST SOC | 12/02/14 STATEMENT OF CAPITAL;GBP 980.28 | |
AR01 | 14/01/14 FULL LIST | |
AP01 | DIRECTOR APPOINTED MR BRYAN GEOFFREY MORTON | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR CHARLES POTTER | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR MARK KIRBY | |
AUD | AUDITOR'S RESIGNATION | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/12 | |
AD01 | REGISTERED OFFICE CHANGED ON 29/05/2013 FROM 45B MILTON PARK ABINGDON OXFORDSHIRE OX14 4RU | |
AP02 | CORPORATE DIRECTOR APPOINTED MEDINNOVATE LTD | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR FRASER SKIRROW | |
SH01 | 22/02/13 STATEMENT OF CAPITAL GBP 280.72 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR JAMES OTTER | |
AP01 | DIRECTOR APPOINTED DR MARK CARNEGIE-BROWN | |
MG02 | DECLARATION OF SATISFACTION IN FULL OR IN PART OF A MORTGAGE OR CHARGE /FULL /CHARGE NO 3 | |
RES01 | ADOPT ARTICLES 18/02/2013 | |
RES12 | VARYING SHARE RIGHTS AND NAMES | |
AR01 | 14/01/13 FULL LIST | |
TM02 | APPOINTMENT TERMINATED, SECRETARY VANESSA YOUNG | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/11 | |
MG02 | DECLARATION OF SATISFACTION IN FULL OR IN PART OF A MORTGAGE OR CHARGE /FULL /CHARGE NO 1 | |
MG02 | DECLARATION OF SATISFACTION IN FULL OR IN PART OF A MORTGAGE OR CHARGE /FULL /CHARGE NO 2 | |
MG01 | PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 3 | |
SH01 | 16/04/12 STATEMENT OF CAPITAL GBP 476.49 | |
SH01 | 19/01/12 STATEMENT OF CAPITAL GBP 476.1056 | |
AR01 | 14/01/12 FULL LIST | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MR JAMES ANTHONY OTTER / 03/02/2012 | |
AP01 | DIRECTOR APPOINTED DR IAN JOSEPH SMITH | |
SH01 | 31/10/11 STATEMENT OF CAPITAL GBP 474.79 | |
RES01 | ALTER ARTICLES 27/05/2011 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
AP01 | DIRECTOR APPOINTED MR JAMES ANTHONY OTTER | |
TM02 | APPOINTMENT TERMINATED, SECRETARY SIMON JONES | |
AP03 | SECRETARY APPOINTED MISS VANESSA JANE YOUNG | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/10 | |
AA01 | PREVSHO FROM 31/03/2011 TO 31/12/2010 | |
AR01 | 14/01/11 FULL LIST | |
CH03 | SECRETARY'S CHANGE OF PARTICULARS / MR SIMON JONES / 01/02/2010 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR RUSSELL SMITH | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR CHARLES SWINGLAND | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR SIMON JONES | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/03/10 | |
RES01 | ALTER ARTICLES 10/03/2010 | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
SH01 | 16/03/10 STATEMENT OF CAPITAL GBP 460.64 | |
SH01 | 03/02/10 STATEMENT OF CAPITAL GBP 460.04 | |
AR01 | 14/01/10 FULL LIST | |
SH01 | 17/12/09 STATEMENT OF CAPITAL GBP 436.10 | |
SH01 | 24/12/09 STATEMENT OF CAPITAL GBP 437.8924 | |
AR01 | 31/12/09 FULL LIST | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / FRASER ANDREW SKIRROW / 31/12/2009 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / CHARLES DAVID OGILVY POTTER / 31/12/2009 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MARK RICHARD KIRBY / 31/12/2009 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / SIMON JONES / 31/12/2009 | |
SH01 | 29/09/09 STATEMENT OF CAPITAL GBP 25.662672 | |
SH01 | 28/09/09 STATEMENT OF CAPITAL GBP 19.1809 | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
RES01 | ALTER ARTICLES 05/08/2009 | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/03/09 | |
RES01 | ADOPT ARTICLES 26/03/2009 | |
363a | RETURN MADE UP TO 31/12/08; FULL LIST OF MEMBERS | |
AUD | AUDITOR'S RESIGNATION | |
363(190) | LOCATION OF DEBENTURE REGISTER ADDRESS CHANGED | |
363s | RETURN MADE UP TO 31/12/07; FULL LIST OF MEMBERS | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/03/08 | |
288c | DIRECTOR'S CHANGE OF PARTICULARS / CHARLES SWINGLAND / 15/02/2008 | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/03/07 | |
123 | NC INC ALREADY ADJUSTED 08/08/07 | |
RES04 | £ NC 500/550 | |
RES01 | ALTERATION TO MEMORANDUM AND ARTICLES | |
395 | PARTICULARS OF MORTGAGE/CHARGE | |
363(190) | LOCATION OF DEBENTURE REGISTER ADDRESS CHANGED | |
363s | RETURN MADE UP TO 31/12/06; FULL LIST OF MEMBERS |
Notice of | 2017-11-23 |
Appointmen | 2017-09-05 |
Total # Mortgages/Charges | 4 |
---|---|
Mortgages/Charges outstanding | 1 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 3 |
Charge Type | Date of Charge | Charge Status | Mortgagee |
---|---|---|---|
DEBENTURE | Satisfied | PHILIP BASIL (THE "SECURITY TRUSTEE") | |
CHARGE | Satisfied | BARCLAYS MERCANTILE BUSINESS FINANCE LIMITED | |
DEBENTURE | Satisfied | BARCLAYS BANK PLC |
|
|
|
|
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED
GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED owns 3 domain names.
caretekmedical.co.uk glidepharma.co.uk sumaglide.co.uk
The top companies supplying to UK government with the same SIC code (72190 - Other research and experimental development on natural sciences and engineering) as GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED are:
Origin | Destination | Date | Import Code | Imported Goods classification description |
---|---|---|---|---|
84798997 | Machines, apparatus and mechanical appliances, n.e.s. | |||
84798997 | Machines, apparatus and mechanical appliances, n.e.s. | |||
84798997 | Machines, apparatus and mechanical appliances, n.e.s. | |||
29372900 | Steroidal hormones, their derivatives and structural analogues, used primarily as hormones (excl. cortisone, hydrocortisone, prednisone "dehydrocortisone", prednisolone "dehydrohydrocortisone", halogenated derivatives of corticosteroidal hormones, oestrogens and progestogens) | |||
29372900 | Steroidal hormones, their derivatives and structural analogues, used primarily as hormones (excl. cortisone, hydrocortisone, prednisone "dehydrocortisone", prednisolone "dehydrohydrocortisone", halogenated derivatives of corticosteroidal hormones, oestrogens and progestogens) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
73181590 | Screws and bolts, of iron or steel "whether or not with their nuts and washers", with heads (excl. slotted and cross-recessed screws and bolts, hexagon head screws and bolts; wood screws, self-tapping screws and screws and bolts for fixing railway track construction material, screw hooks, screw rings and lag screws) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
84433990 | Printers and facsimile machines (excl. those capable of connecting to an automatic data processing machine or to a network) | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
84798930 | Mobile hydraulic powered mine roof supports | |||
29371900 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts) | |||
84799080 | Parts of machines and mechanical appliances having individual functions, n.e.s. (excl. of cast iron or cast steel) | |||
90189084 | Instruments and appliances used in medical, surgical or veterinary sciences, n.e.s. | |||
84799080 | Parts of machines and mechanical appliances having individual functions, n.e.s. (excl. of cast iron or cast steel) | |||
90279050 | Parts and accessories of instruments and apparatus for physical or chemical analysis, e.g. polarimeters, refractometers, spectrometers, of instruments and apparatus for measuring or checking viscosity, porosity, expansion, surface tension or the like and of instruments and apparatus for measuring or checking quantities of heat, sound or light, incl. exposure meters, n.e.s. (excl. of gas or smoke analysis apparatus) | |||
84799080 | Parts of machines and mechanical appliances having individual functions, n.e.s. (excl. of cast iron or cast steel) |
For goods imported into the United Kingdom, only imports originating from outside the EU are shown
Initiating party | Event Type | Notice of | |
---|---|---|---|
Defending party | GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED | Event Date | 2017-11-23 |
Category | Award/Grant | |
---|---|---|
Room temperature stable solid vaccine formulations suitable for needle free delivery : Feasibility Study | 2013-06-01 | £ 150,000 |
Novel Teriparatide (PTH) Formulation : Feasibility Study | 2013-04-01 | £ 2,287,895 |
Novel epinephrine formulations : Smart - Development of Prototype | 2012-06-01 | £ 250,000 |
How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |